===
EQS-News: Cantourage Group SE / Key word(s): Monthly Figures
Cantourage Group SE: Strong growth continues - another monthly sales record in June 2024
2024-07-03 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Not for release, publication or distribution, directly or indirectly, in or into the United States of America,
Australia, Canada or Japan or any other jurisdiction in which such release, publication or distribution would be
unlawful. The important notes at the end of this announcement need to be observed.

Cantourage Group SE: Strong growth continues - another monthly sales record in June 2024
. High growth dynamics since the partial legalization of cannabis in Germany came into force continue and
gain further momentum
. Monthly sales increased to EUR 4.1 million in June 2024
. Cantourage and Telecan establish themselves as a main point of contact for patients
Berlin, July 03, 2024 - Cantourage Group SE (hereinafter referred to as "Cantourage," ISIN: DE000A3DSV01,
www.cantourage.com), a leading European company for the production and distribution of cannabis, once again achieved
record monthly sales in June 2024. Sales revenue of EUR 4.1 million was generated in the period. Cantourage had already
set a new record for sales in the previous month (sales in May 2024: EUR 3.5 million) as a result of the noticeable
increase in demand for high-quality cannabis products.
Since the partial legalization of cannabis in Germany came into effect in April 2024, the demand for cannabis products
in pharmacies has increased significantly. At the same time, Cantourage is also continuously expanding its
collaboration with doctors as part of its online platform for cannabis on prescription, Telecan (www.telecan.eu). This
provides more and more patients with a simple and direct route to cannabis therapy. Overall, Cantourage's business has
grown dynamically in all core areas most recently.
"Thanks to our flexible business model, we have prepared for the ongoing liberalization of cannabis in Germany and
other European countries at an early stage in recent years. In doing so, we were able to bring on board many well-known
cannabis growers from all over the world as partners and also expand our own production capacities in time for the
expected increase in demand. We have benefited greatly from this, particularly since April 2024. We now expect the
positive growth momentum from the second quarter to continue in the second half of 2024," said Philip Schetter, CEO of
Cantourage.

About Cantourage
Cantourage is a leading European producer and distributor of cannabis flowers and cannabis-based medicinal preparations
and drugs. The Berlin-based company was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel
and Patrick Hoffmann. With an experienced management team and its "Fast Track Access" platform, Cantourage enables
producers from around the world to become part of the growing European medical cannabis market faster, easier and more
cost-effectively by processing and distributing their cannabis raw materials and extracts. In this context, Cantourage
ensures compliance with the highest European pharmaceutical quality standards at all times. The company offers
pharmaceutical-grade products in all relevant market segments: dried flower, extracts, dronabinol and cannabidiol.
Cantourage was listed on the Frankfurt Stock Exchange on 11 November 2022 and is listed under ticker symbol "HIGH."
Further information: www.cantourage.com

This announcement does not constitute a public offer or an advertisement for a public offer to sell securities, in
particular not within the meaning of Regulation (EU) 2017/1129 (Prospectus Regulation).

Press contact at Cantourage:
Frederick Steudemann
Phone: +49 (0)30 4701 350 - 50
steudemann@cantourage.com


2024-07-03 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com  
Language:     English 
Company:      Cantourage Group SE 

Feurigstraße 54
10827 Berlin
Germany

E-mail:       info@cantourage.com 
Internet:     https://www.cantourage.com/ 
ISIN:         DE000A3DSV01 
WKN:          A3DSV0 
Listed:       Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Munich, Stuttgart, Tradegate 

Exchange
EQS News ID: 1938195

End of News EQS News Service
===
1938195 2024-07-03 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1938195&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face

END) Dow Jones Newswires

July 03, 2024 02:00 ET (06:00 GMT)